Loading...
The use of natalizumab for multiple sclerosis
Natalizumab is a monoclonal antibody that acts as an α4 integrin antagonist to prevent leukocyte trafficking into the central nervous system. It is US Food and Drug Administration (FDA) approved for the treatment of relapsing–remitting multiple sclerosis (RRMS). Natalizumab demonstrated high efficac...
Saved in:
Published in: | Neuropsychiatr Dis Treat |
---|---|
Main Authors: | , |
Format: | Artigo |
Language: | Inglês |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5499927/ https://ncbi.nlm.nih.gov/pubmed/28721050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S114636 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|